enow.com Web Search

  1. Ad

    related to: astrazeneca lung cancer drugs list a z

Search results

  1. Results from the WOW.Com Content Network
  2. Category:Drugs developed by AstraZeneca - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed...

    Pages in category "Drugs developed by AstraZeneca" The following 133 pages are in this category, out of 133 total. This list may not reflect recent changes. A.

  3. AstraZeneca's Imfinzi improves survival in late-stage lung ...

    www.aol.com/news/astrazenecas-imfinzi-shows...

    The U.S. Food and Drug Administration first approved the drug in 2017 to treat a type of bladder cancer. Imfinzi won approval for use in mid-stage non-small cell lung cancer a year later.

  4. PD-1 and PD-L1 inhibitors - Wikipedia

    en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors

    Sintilimab (IBI308), a human anti-PD-1 antibody developed by Innovent and Eli Lilly for patients with non-small cell lung cancer . [27] INCMGA00012 (MGA012) is a humanized IgG4 monoclonal antibody developed by Incyte and MacroGenics. [28] AMP-224 by AstraZeneca/MedImmune and GlaxoSmithKline [29] AMP-514 (MEDI0680) by AstraZeneca [30]

  5. Durvalumab - Wikipedia

    en.wikipedia.org/wiki/Durvalumab

    The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...

  6. AstraZeneca says lung cancer drug trial shows no significant ...

    www.aol.com/news/astrazeneca-says-lung-cancer...

    The trial compared the two treatments -- AstraZeneca's drug and chemotherapy -- of patients whose non-small cell lung cancer had returned after one or two prior treatment attempts.

  7. AstraZeneca's Investigational Cancer Drug Disappoints ... - AOL

    www.aol.com/astrazenecas-investigational-cancer...

    Monday, AstraZeneca Plc (NASDAQ:AZN) shared detailed results from the TROPION-Lung01 Phase 3 of datopotamab deruxtecan (Dato-DXd) compared to docetaxel, the current standard of care chemotherapy ...

  8. AstraZeneca's Imfinzi gets FDA priority review for type of ...

    www.aol.com/news/astrazenecas-imfinzi-gets-fda...

    AstraZeneca's application was based on positive late-stage data that showed the drug improved overall survival and progression-free survival in patients with a type of lung cancer, whose disease ...

  9. Saracatinib - Wikipedia

    en.wikipedia.org/wiki/Saracatinib

    Saracatinib (AZD-0530) is an experimental drug being developed by AstraZeneca. It acts as a dual kinase inhibitor, with selective actions as a Src inhibitor and a Bcr-Abl tyrosine-kinase inhibitor. [1] [2]

  1. Ad

    related to: astrazeneca lung cancer drugs list a z